Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Agile Therapeutics - 10 Year Stock Split History | AGRX

Stock split history for Agile Therapeutics since 2014. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
  
Agile Therapeutics Annual Stock Splits
Agile Therapeutics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.003B $0.020B
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.585B 5.27
Dr Reddy's Laboratories (RDY) India $11.930B 18.86
Aspen Pharmacare (APNHY) South Africa $4.985B 0.00
BridgeBio Pharma (BBIO) United States $4.477B 0.00
Bausch Health Cos (BHC) Canada $3.117B 2.43
Amphastar Pharmaceuticals (AMPH) United States $1.999B 13.68
Supernus Pharmaceuticals (SUPN) United States $1.639B 0.00
Taysha Gene Therapies (TSHA) United States $0.473B 0.00
Generation Bio (GBIO) United States $0.217B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.070B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00